Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Details

Connection

Lynn Hassman to Infliximab

This is a "connection" page, showing publications Lynn Hassman has written about Infliximab.

 
Connection Strength
  
 
 
0.055
  
  1. Shunyakova J, Patnaik JL, Xia J, Hassman LM, Pecen PE, Palestine AG, Reddy AK. Immunomodulatory Therapy Discontinuation for Reasons Other Than Efficacy in the Treatment of Ocular Inflammation. Ocul Immunol Inflamm. 2025 Oct; 33(8):1807-1810.
    View in: PubMed
    Score: 0.055
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)